Comparison

S-methyl-KE-298 European Partner

Item no. TMO-T4282-1mg
Manufacturer TargetMol
CASRN 143584-75-2
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations Yoshida H , Kohno Y , Endo H , et al. Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats[J]. Chirality, 2015, 9(1):22-28.
Smiles C(CC(CSC)C(O)=O)(=O)C1=CC=C(C)C=C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 143584-75-2,MMP
Shipping Condition Cool pack
Available
Manufacturer - Targets
Drug Metabolite|||MMP
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
252.33
Description
S-methyl-KE-298 is the second main metabolite in plasma, is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from  rheumatoid arthritis (RA) synovial cells.
Pathways
Metabolism|||Proteases/Proteasome

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close